Proactiveinvestors Australia Agenus Inc https://www.proactiveinvestors.com.au Proactiveinvestors Australia Agenus Inc RSS feed en Sun, 20 Sep 2020 21:33:01 +1000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Agenus partners with Gilead Sciences to develop five immuno-oncology therapies https://www.proactiveinvestors.com.au/companies/news/211599/agenus-partners-with-gilead-sciences-to-develop-five-immuno-oncology-therapies-211599.html Thu, 20 Dec 2018 15:42:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211599/agenus-partners-with-gilead-sciences-to-develop-five-immuno-oncology-therapies-211599.html Agenus to benefit from malaria vaccine partnership with GlaxoSmithKline https://www.proactiveinvestors.com.au/companies/news/114381/agenus-to-benefit-from-malaria-vaccine-partnership-with-glaxosmithkline-114381.html Mon, 27 Jul 2015 15:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/114381/agenus-to-benefit-from-malaria-vaccine-partnership-with-glaxosmithkline-114381.html Agenus maintains “buy” at HCW on heels of CEACAM1 acquisition https://www.proactiveinvestors.com.au/companies/news/114380/agenus-maintains-buy-at-hcw-on-heels-of-ceacam1-acquisition-114380.html Mon, 20 Jul 2015 20:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/114380/agenus-maintains-buy-at-hcw-on-heels-of-ceacam1-acquisition-114380.html Agenus target raised to $7 at H.C. Wainwright; "undervalued player in immuno-oncology" https://www.proactiveinvestors.com.au/companies/news/105704/agenus-target-raised-to-7-at-hc-wainwright-undervalued-player-in-immuno-oncology-60144.html Fri, 27 Feb 2015 18:14:00 +1100 https://www.proactiveinvestors.com.au/companies/news/105704/agenus-target-raised-to-7-at-hc-wainwright-undervalued-player-in-immuno-oncology-60144.html Agenus soars on collaboration with Incyte, seen as "major validation" https://www.proactiveinvestors.com.au/companies/news/104987/agenus-soars-on-collaboration-with-incyte-seen-as-major-validation-59183.html Shares of Agenus (NASDAQ:AGEN) rocketed more than 30 percent today after the company announced a co-development collaboration with Incyte (NASDAQ:INCY) to develop immuno-oncology antibodies.

]]>
Fri, 09 Jan 2015 18:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/104987/agenus-soars-on-collaboration-with-incyte-seen-as-major-validation-59183.html
Agenus shares climb on "best-in-class" phase 3 shingles vaccine study, says H.C. Wainwright https://www.proactiveinvestors.com.au/companies/news/104781/agenus-shares-climb-on-best-in-class-phase-3-shingles-vaccine-study-says-hc-wainwright-58925.html Fri, 19 Dec 2014 14:06:00 +1100 https://www.proactiveinvestors.com.au/companies/news/104781/agenus-shares-climb-on-best-in-class-phase-3-shingles-vaccine-study-says-hc-wainwright-58925.html Agenus inks licensing deal for Oncophage vaccine in Russia https://www.proactiveinvestors.com.au/companies/news/82325/agenus-inks-licensing-deal-for-oncophage-vaccine-in-russia-22710.html Tue, 20 Dec 2011 12:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/82325/agenus-inks-licensing-deal-for-oncophage-vaccine-in-russia-22710.html Agenus reports positive results for its HerpV drug https://www.proactiveinvestors.com.au/companies/news/80082/agenus-reports-positive-results-for-its-herpv-drug-18832.html Mon, 26 Sep 2011 16:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/80082/agenus-reports-positive-results-for-its-herpv-drug-18832.html